Q9978 Netupitant 300 mg and palonosetron 0.5 mg

Short descriptor: Netupitant palonosetron oral

⚠ Terminated HCPCS Level II 2026
Terminated Code
Q9978 was terminated as of 2015-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open Q9978 in the app →

Look up Q9978 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q9978 is the HCPCS Level II code for Netupitant 300 mg and palonosetron 0.5 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2016-01-01
Termination Date
2015-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference Q9978 with the canonical source and edition:

Q9978 — Netupitant 300 mg and palonosetron 0.5 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q9978

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q9978

Related Codes in Section Q

← Q9977 Compounded drug noc Q9979 → Injection, alemtuzumab
Q9974 Morphine epidural/intratheca Q9975 Factor viii fc fusion recomb Q9976 Inj ferric pyrophosphate cit Q9977 Compounded drug noc Q9979 Injection, alemtuzumab Q9980 Genvisc, inj, 1mg Q9981 Rolapitant, oral, 1mg Q9982 Flutemetamol f18 diagnostic Q9983 Florbetaben f18 diagnostic Q9984 Kyleena, 19.5 mg
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial